| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 77,807 | 51,017 |
| Depreciation and amortization | 717 | 609 |
| Amortization of intangible assets | 431 | 287 |
| Deferred income tax expense | 5,786 | 3,001 |
| Provision for credit losses | 10,787 | 5,486 |
| Stock-based compensation expense | 4,935 | 3,157 |
| Net loss from equity method investments | -1,860 | -2,458 |
| Net loss on sale of securities available for sale and other assets | -2,946 | -1,721 |
| Net loss (gain) on sale of loans and change in fair value on loans held-for-sale, net | 920 | 850 |
| Net gain on death benefits of bank-owned life insurance | 562 | 160 |
| Proceeds from sales of loans originated as held for sale | 20,635 | 9,206 |
| Originations of loans held for sale | 22,065 | 10,624 |
| Increase in cash surrender value of bank-owned life insurance | 1,910 | 1,262 |
| Net gain on repurchase of subordinated debt | 0 | 0 |
| Decrease in accrued interest receivable | -4,108 | -5,663 |
| Decrease in other assets | -549 | -1,200 |
| Decrease in other liabilities | -6,466 | -11,770 |
| Net cash provided by operating activities | 98,638 | 59,139 |
| Net increase in loans | 127,171 | 43,895 |
| Proceeds from sales of loans originated as held for investment | 34,844 | 34,844 |
| Purchase of securities available for sale | 761,174 | 473,312 |
| Purchase of securities held-to-maturity | 65,551 | 35,231 |
| Proceeds from sales of securities available for sale | 120,188 | 56,136 |
| Maturities, principal payments and redemptions of securities available for sale | 328,630 | 189,161 |
| Maturities, principal payments and redemptions of securities held-to-maturity | 140,144 | 55,293 |
| Increase in resell agreements | -35,215 | -33,299 |
| Decrease in equity method investments | 94 | 914 |
| Decrease (increase) in fhlbny stock, net | -10,416 | -10,416 |
| Purchases of premises and equipment, net | 2,234 | 1,041 |
| Proceeds from redemption of bank-owned life insurance | 983 | 983 |
| Proceeds from sale of owned assets | 46 | 46 |
| Net cash used in investing activities | -356,000 | -238,985 |
| Net increase in deposits | 589,364 | 552,667 |
| Net decrease in other borrowings | -238,994 | -238,994 |
| Repurchase of subordinated debt | 0 | 0 |
| Common stock issued under equity programs | 1,237 | 1,033 |
| Repurchase of common stock | 23,632 | 13,188 |
| Dividends paid on common stock | 13,013 | 8,767 |
| Payments related to repurchase of common stock for equity awards | 2,805 | 2,588 |
| Net cash provided by financing activities | 312,157 | 290,163 |
| Increase in cash, cash equivalents, and restricted cash | 54,795 | 110,317 |
| Cash and cash equivalents at beginning of period | 60,749 | - |
| Cash and cash equivalents at end of period | 115,544 | - |
Amalgamated Financial Corp. (AMAL)
Amalgamated Financial Corp. (AMAL)